中文
About Us
GV-971
Scientific Research Information
News
Social Responsibility
Careers
Contact Us
CN
About Us
GV-971
Scientific Research Information
News
Social Responsibility
Careers
Contact Us
News Reports
News Reports
Press Releases
News Reports
Press Releases
News Reports
CCTV-NEWS | GV-971, a novel AD drug treatment developed by Chinese research team, grabs much of attention at CTAD
Date:2018-10-30
ShareTo:
Previous Page:
Fits and Starts: Trial Results from the CTAD Conference
Next Page:
YAHOO! | Innovative Alzheimer's Treatment from China Concludes Phase 3 Clinical Trials